Summary
Altered exocrine gland function is characteristic of cystic fibrosis (CF). This study was undertaken to determine the relationship between pancreatic and salivary exocrine dysfunction in CF. We have measured serum pancreatic (P) and salivary-like (S) isoenzyme concentrations in C F patients, their obligate heterozygote parents and normal controls (N) using a quantitative gel-electrophoretic method. Our results show that serum levels of these isoenzymes correlate with the respective pancreatic and salivary gland amylase output and, therefore, can be used a s measures of pancreatic and salivary exocrine function. Thus, P isoenzyme levels are low in C F patients with pancreatic insufficiency (mean +-S.D.: 1.3 + 0.6 starch units per liter versus 5.8 f 1.7 for the N group, P < 0.001). In contrast, P isoenzyme levels are elevated in C F patients with adequate pancreatic function (12.0 + 5.3; P < 0.002 versus N). Whereas P isoenzyme levels differentiate C F patients with pancreatic insufficiency from those with adequate pancreatic function, S isoenzyme levels are equally elevatedirrespective of pancreatic function (12.5 + 5.3 and 12.5 + 5.2 versus 8.1 2.7 for the N group, P < 0.001 and < 0.01, respectively).
Thus, increased salivary amylase levels in CF patients are not due to a compensatory mechanism for reduced pancreatic amylase output, but rather are intrinsic to CF. In those patients with adequate pancreatic function, the increased S isoenzyme levels correlate with increased P levels ( r = 0.72). indicating defective control of both pancreatic and salivary exocrine secretion in CF. In obligate heterozygote samples, P isoenzyme levels are increased (7.6 f 2.5; P < 0.05 versus N) whereas S isoenzyme levels are normal (8.2 + 5.6), indicating that this defect is partially expressed in the carrier state. We conclude that elevated saliva amylase and altered serum amylase isoenzyme levels in the C F patient and carrier state are due to a generalized defect in exocrine gland secretory regulation in CF.
Speculation
We speculate that the altered exocrine secretion in cystic fibrosis patients and their parents is due to the presence of an extra, cystic-fibrosis-associated, stimulatory agent and that the exocrine pancreas is more sensitive to this agent than are the salivary glands.
Cystic fibrosis (CF) is the most common lethal genetic disease of Caucasians. Although the basic pathophysiologic defect has not been determined, the clinical triad of chronic pulmonary disease, pancreatic insufficiency, and increased sweat electrolyte concentration has been ascribed to a defect in the control of exocrine gland secretion (6).
Our previous work (8, 9) and that of others (2, 6) has shown that amylase activity (a-D-glucan 4-glucanohydrolase, EC 3.2.1.1) is increased in saliva of C F patients. This increased activity could be due to a primary defect in regulation of exocrine secretion in C F or be a compensatory mechanism for the decreased pancreatic amylase secretion in the 80% of C F patients with pancreatic insufficiency. Altered exocrine function of the pancreatic or salivary glands is reflected in alterations of the respective pancreatic (P) or salivary-like (S) amylase isoenzyme concentrations in serum (1, 14, 22) . Therefore, to differentiate between the two hypotheses, we have measured serum amylase isoenzyme levels and determined the relationship between salivary and pancreatic amylase output in the C F genotype.
MATERIALS AND METHODS
Specimens were collected from patients with C F (age. 5 to 35 years), their obligate heterozygote parents (H) (age, 26 to 47 years) and normal control donors (N) (age, 5 to 47 years) after obtaining informed consent. Blood was obtained by venipuncture and was transferred to red-top vacutainers, allowed to clot, and centrifuged to obtain the serum. Whole saliva (3 to 5 ml) was collected without a stimulant into plastic tubes and centrifuged at 5000 x g for 15 rnin to obtain a clear supernate. Samples were stored at -20°C until assayed.
C F patients were divided into two groups on the basis of clinical and laboratory assessment of pancreatic function. Group A had pancreatic iniufficiency, and group B had adequate pancreatic function. The clinical diagnosis of pancreatic insufficiency in C F patients was based on a history of steatorrhea. low serum carotene levels, and the need forsnzyme replacement therapy. Pancreatic insufficiency was further confirmed in six patients by pancreatic secretory studies with duodenal intubation as described by Cox et a/. (3). Adequate pancreatic function was defined by absence of clinical evidence of pancreatic insufficiency and either no use (6 patients) or minimal use (2 patients) of enzyme replacement therapy.
Total serum and saliva amylase activities were determined by a saccharogenic assay as previously described (7, 8). Activity Ls expressed in starch units/liter. One starch unit is equal to 5.7
Somogyi units (13) and 10.6 1U ( 16).
Serum amylase can be separated by polyacrylamide gel electrophoresis into two principal groups: P isoenzymes and S isoenzymes (7). The P isoenzymes are derived from the pancreas (I). The primary source of the S isoenzymes are the salivary glands, but other organs may also contribute to this fraction ( I , 16).
The S and P isoenzymes in serum were separated and quantitated as recently described (7). Briefly, after electrophoresis of serum on 7.2% polyacrylamide gel, the gel was incubated in phosphate-buffered starch solution and stained with 12/KI. The relative activities of the S and P isoenzymes were quantitated by densitometry. This method can measure activity as low as 0.2 starch unit/liter/band. It has a reproducibility CV = 0.04 and a precision CV = 0.03 for normal samples (7).
RESULTS
The separation of serum amylase isoenzymes on polyacrylamide gels is illustrated in Figure I . Normal serum contains S and P bands of about equal intensity (Fig. IA) . C F patients with pancreatic insufficiency have a normal S band, but a very faint P band (Fig. IB) . A variant pattern, with a second band of pancreatic origin trailing the usual P band (Fig. I C ) (12) was also observed.
T o establish that the serum levels of P isoenzyme were related to pancreatic amylase output, P levels in patients who had pancreatic insufficiency confirmed by duodenal intubation were compared to levels in patients who did not use any enzyme replacement therapy. The data is summarized in Table I . All six study patients with confirmed pancreatic insufficiency (group A) had very low P isoenzyme levels. The six study patients who had clinically normal pancreatic function (group B) had much higher serum P isoenzyme activity. These results. confirming earlier studies (22, 24) indicate that serum P isoenzyme levels are a good measure of pancreatic exocrine function in CF.
To establish that serum S isoenzyme levels are related to saliva amylase levels, serum S isoenzyme and saliva amylase were determined in 51 pairs of serum and saliva samples from CF. H, and N donors. A scatter plot of the data is shown in Figure 2 . Linear regression analysis gives a correlation coefficient of r = 0.50: P < 0.001. Thus, there is a highly significant correlation between serum S isoenzyme activity and saliva amylase activity. We conclude A B C An alternate explanation for increased S isoenzyme levels in C F patient sera would be increased output of amylase by the diseased lung. This possibility is suggested by recent reports of increased S isoenzyme levels in cases of pneumonia and cancer (6 21).
Therefore, we analyzed S isoenzyme levels as a function of the Xray and the pulmonary components of the patient's Schwachman score. There was no correlation between either of these indices of lung disease and the S isoenzyme levels: r = -0.25 and -0.16; P > 0.05, for both. Thus, lung amylase output secondary to lung disease is not a primary contributor to serum S isoenzyme levels in CF. Instead, based on the significant correlation between serum S and saliva amylase levels. we conclude that saliva amylase output is the primary source of serum S isoenzyme in C F patients.
To determine the relationship between pancreatic and salivary amylase output in CF, we analyzed total serum amylase S and P isoenzyme activity with respect to C F genotype and pancreatic function. Inasmuch as there is still uncertainty about the normal range of serum amylase isoenzyme distribution below 5 years of age (15, 19, 23) . only samples from donors aged 5 years and over were analyzed. Mean values for total serum amylase, %P, and P and S isoenzyme activity for the CF. H, and N groups are listed in Table 2 .
The C F patients with pancreatic insufficiency have normal total serum amylase. In these subjects, P isoenzyme activity is greatly reduced, consistent with the diagnosis of pancreatic acinar failure. In contrast. S isoenzyme activity is significantly elevated and accounts for the normal level of total serum amylase. The amylase content of saliva is also elevated in this group.
The C F patients with adequate pancreatic function have elevated total serum amylase activity. The increased serum amylase is the result of significant increases in both the P and S isoenzyme activities. In parallel with increased serum S activity, saliva amylase activity is also elevated in this group.
The H group (parents of C F patients) has total serum amylase activity within the normal range, but an altered distribution of P and S isoenzyme, with increased P isoenzyme activity and increased mean %P. However, there is overlap between the H and N range of absolute and relative P values (vide infra).
The relationship between S and P isoenzyme levels in C F genotypes was further analyzed with a scatter plot (Fig. 3 ). S and P levels in N sera are significantly correlated, with P < 0.001 (Fig.  3A ). S and P levels are also correlated in H sera with P < 0.01 (Fig. 3B) . Analysis of variance for P versus S indicates that the H population is significantly different from the N population: F = 4.47; P < 0.02. Compared to N samples, the H samples have greater P activity for a given S activity. This shift accounts for the observed increase in %P values in H samples.
The relationship between S and P values differs in the two C F groups. In sera of C F patients with adequate pancreatic function, the increases in S and P values are correlated (Fig. 3C, solid  circles) . Sera of C F patients with pancreatic insufficiency have a similar range of S values, but all have very low P values, so there is no correlation between S and P values in this group (Fig. 3C . open circles ). pancreatic insufficiency and elevated in patients with adequate pancreatic function (Table 2) confirms the recent report of Davidson et al. (5). These authors found normal total serum amylase in C F patients with steatorrhea, but below normal total serum amylase in Schwachman's syndrome patients. Inasmuch as the total serum amylase in both of these patient groups with pancreatic insufficiency is comprised virtually completely of S isoenzyme, Davidson et al. concluded that elevated S isoenzyme is intrinsic to C F and not a secondary manifestation of pancreatic insufficiency.
Our direct measurements of S isoenzyme and salivary amylase activity in C F patients confirm that these are elevated in CF patients regardless of pancreatic function. Thus, salivary amylase hypersecretion is not secondary to decreased pancreatic amylase production.
Our finding that P isoenzyme levels reflect pancreatic amylase output confirms the earlier reports of Taussig er al. (22) and Wolf er al. (24) that serum P isoenzyme levels are useful for the diagnosis of pancreatic insufficiency in CF. However, serum amylase isoenzyme levels are low in normal newborns (15, 19, 23) . Adult levels have been reported to be reached as early as 8 months (23) and as late as 10 to 15 years of age (19). This disagreement on the normal development of serum amylase isoenzyme activity needs to be resolved, and the normal ranges of P and S isoenzymes need to be defined for the 0-to 5-year group before application of serum amylase isoenzyrne levels for the diagnosis of pancreatic insufficiency in the younger child with CF.
Our data further show that pancreatic as well as salivary amylase seems elevated in C F patients with adequate pancreatic function, i.e., those with residual acinar function. This is consistent with reports of recurrent acute pancreatitis in C F patients who do not have pancreatic insufficiency (18). It suggests that increased concentration of macromolecules in the pancreatic duct may precede the plugging of these ducts in those patients who ultimately develop pancreatic insufficiency. However the fact that hypersecretion is present in k~ patients with adequate pancreatic function is evidence that hv~ersecretion per se, is not a sufficient explanation for duct and the dkveIopment of -~ -pancreatic insufficiency and that some other contributing events DISCUSSION must also be involved. There is some indication that serum P isoenzyme levels may be These studies demonstrate that serum P and S amylase isoen-elevated in the C F neonate. Studies with autopsy material have zyme levels in C F patients correlate with their pancreatic and shown that pancreatic acinar changes can begin in utero for the salivary gland amylase output and therefore that P and S levels C F fetus (10). although the progression of pancreatic disease after can be used as measures of pancreatic and salivary exocrine birth can be very rapid or be clinically indiscernible (1 1). Crossley function in the C F patient. Our finding that total serum amylase, et al. (4) have reported a study of five neonates with C F whose the sum of P and S activity, is normal in C F patients with initial serum levels of immunoreactive trypsin were markedly (8) . The mean age of the patient population was 18 f 8 years; that of the control population of the same age (5 to 35 years) was also 18 f 8 years (n = 45).
" Mean value calculated from individual %P values, not from the mean P and mean total amylase values.
Mean * S.D.
" CF patients with pancreatic insufficiency.
" P < 0.00 1 versus N. CF patients with adequate pancreatic function ' P < 0.002 versus N .
!'P < 0.0 1 versus N.
"' P < 0.05 versus N.
